Zantac Lawsuits Point To An Array of Negligence By Sanofi

The allegations against Sanofi continue to grow as individuals file lawsuits

Monday, December 7, 2020 - It is still early in the game for people that have developed cancer allegedly due to taking Zantac. Legal minds think that the number of lawsuits could be in the thousands before all is said and done. It has been less than a year since the Food and Drug Administration (FDA) recalled all brands and generic forms of ranitidine, a type of H2 histamine blocker that prevents the stomach from producing excess acid when evidence of it containing a carcinogenic substance emerged. Online drug testing pharmacy Valisure discovered elevated levels of NDMA, a well-known carcinogen, in Zantac and other heartburn and acid reflux medications, thousands of times greater than the FDA acceptable level of 96 ng per tablet. Individuals that have taken Zantac regularly for more than one year are filing lawsuits alleging they have developed a wide variety of types of cancer from the stomach, bladder, and esophageal cancer, to prostate, intestinal, and even breast cancer. About Lawsuits.com (AL) describes the latest individual to accuse Sanofi, the maker of Zantac, of failing to warn the public of what they knew or had an obligation to know about hazardous levels of NDMA in the world's best-selling heartburn medicine, and many other accusations. Zantac stomach cancer attorneys offer a free no obligation consultation before filing a claim.

Oswald Anfossi of Florida filed a lawsuit the other day according to AL, alleging that he took Zantac purchased over the counter for more than two years and developed gall bladder and stomach cancer. "According to the lawsuit, Anfossi took over-the-counter versions of Zantac for about two years starting in 2017 and was diagnosed with stomach cancer and gall bladder damage in 2019. The injuries are attributed to regular exposure to high levels of the known carcinogen N-Nitrosodimethylamine (NDMA), which are produced by ranitidine in Zantac during storage or as it passes through the body," according to AL. The website also indicates the nature of the lawsuit and enumerates the degrees of negligence Sanofi has allegedly committed, "The lawsuit presents claims of a failure to warn, design defect, manufacturing defect, negligence, negligent product design, negligent manufacturing, negligent misrepresentation, breach of warranties, violation of consumer protection and deceptive trade practices laws and unjust enrichment."

Sanofi is currently under investigation by the Securities and Exchange Commission and the Department of Justice for allegations the company lied to the government about their knowledge of Zantac NDMA levels. NDMA is a carcinogenic substance and a byproduct of industrial production like that which goes unregulated in China and India where about 85% of the drugs consumed in the United States are produced or originate. NDMA can be found in the air, water, and land surrounding industrial production facilities. Experts suspect that the cause of NDMA contamination could be at the source in China and India. Other possibilities for NDMA contamination could be overheating ranitidine, or when ranitidine mixes with nitrates in the stomach. Individuals that have developed cancer and have taken Zantac regularly for a long time should consult a Zantac Cancer Lawyer to discuss their legal options.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.